Pleiotropy of autism-associated chromatin regulators.


Journal

Development (Cambridge, England)
ISSN: 1477-9129
Titre abrégé: Development
Pays: England
ID NLM: 8701744

Informations de publication

Date de publication:
15 07 2023
Historique:
received: 07 12 2022
accepted: 19 06 2023
medline: 19 7 2023
pubmed: 27 6 2023
entrez: 27 6 2023
Statut: ppublish

Résumé

Gene ontology analyses of high-confidence autism spectrum disorder (ASD) risk genes highlight chromatin regulation and synaptic function as major contributors to pathobiology. Our recent functional work in vivo has additionally implicated tubulin biology and cellular proliferation. As many chromatin regulators, including the ASD risk genes ADNP and CHD3, are known to directly regulate both tubulins and histones, we studied the five chromatin regulators most strongly associated with ASD (ADNP, CHD8, CHD2, POGZ and KMT5B) specifically with respect to tubulin biology. We observe that all five localize to microtubules of the mitotic spindle in vitro in human cells and in vivo in Xenopus. Investigation of CHD2 provides evidence that mutations present in individuals with ASD cause a range of microtubule-related phenotypes, including disrupted localization of the protein at mitotic spindles, cell cycle stalling, DNA damage and cell death. Lastly, we observe that ASD genetic risk is significantly enriched among tubulin-associated proteins, suggesting broader relevance. Together, these results provide additional evidence that the role of tubulin biology and cellular proliferation in ASD warrants further investigation and highlight the pitfalls of relying solely on annotated gene functions in the search for pathological mechanisms.

Identifiants

pubmed: 37366052
pii: 324019
doi: 10.1242/dev.201515
pmc: PMC10399978
pii:
doi:

Substances chimiques

Chromatin 0
Tubulin 0
Histones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIMH NIH HHS
ID : U01 MH115747
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH116487
Pays : United States

Informations de copyright

© 2023. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Références

Nature. 2012 Apr 04;485(7397):242-5
pubmed: 22495311
Cell Syst. 2017 Jun 28;4(6):587-599.e4
pubmed: 28601559
Nat Commun. 2015 Mar 10;6:6404
pubmed: 25752243
Neuron. 2016 May 4;90(3):551-63
pubmed: 27112495
Curr Biol. 2013 Dec 16;23(24):2443-51
pubmed: 24268414
Nat Genet. 2022 Sep;54(9):1320-1331
pubmed: 35982160
Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
J Cell Biol. 1987 Nov;105(5):2191-201
pubmed: 3680377
J Biol Chem. 2007 Nov 23;282(47):34448-56
pubmed: 17878164
Trends Cell Biol. 2022 Feb;32(2):98-101
pubmed: 34610892
Cell. 2016 Aug 11;166(4):950-962
pubmed: 27518565
Cell. 2014 Jul 17;158(2):263-276
pubmed: 24998929
Trends Cell Biol. 2016 Mar;26(3):161-164
pubmed: 26786773
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5533-5541
pubmed: 30837315
Parkinsonism Relat Disord. 2018 Jul;52:55-61
pubmed: 29653907
Nature. 2018 May;557(7707):739-743
pubmed: 29795351
Cell Mol Life Sci. 2015 Jan;72(1):11-23
pubmed: 25173771
Am J Med Genet A. 2020 Jan;182(1):38-52
pubmed: 31782611
Nat Rev Mol Cell Biol. 2020 Jun;21(6):307-326
pubmed: 32107477
Genesis. 2012 Mar;50(3):155-63
pubmed: 22253050
Nat Rev Neurosci. 2022 Jun;23(6):323-341
pubmed: 35440779
Cell. 2015 Jul 16;162(2):375-390
pubmed: 26186191
PLoS Biol. 2018 Jul 3;16(7):e2005970
pubmed: 29969450
EMBO J. 2019 Jul 15;38(14):e101109
pubmed: 31304627
Dev Biol. 2007 Mar 15;303(2):814-24
pubmed: 17222401
Cell Syst. 2018 Apr 25;6(4):484-495.e5
pubmed: 29605183
Am J Hum Genet. 2013 Nov 7;93(5):967-75
pubmed: 24207121
Cell Stem Cell. 2021 Dec 2;28(12):2153-2166.e6
pubmed: 34536354
Cell Stem Cell. 2020 Feb 6;26(2):221-233.e6
pubmed: 32004479
J Genet Genomics. 2022 Sep;49(9):881-890
pubmed: 35331928
J Neurochem. 1999 Mar;72(3):1283-93
pubmed: 10037502
Cell. 2001 Jan 12;104(1):83-93
pubmed: 11163242
Front Mol Neurosci. 2019 Jan 14;11:481
pubmed: 30692911
Neuron. 2021 Apr 21;109(8):1409
pubmed: 33887193
Biol Psychiatry. 2021 Mar 1;89(5):486-496
pubmed: 32826066
Mol Biol Cell. 2007 Sep;18(9):3667-80
pubmed: 17626165
Mol Biol Cell. 2020 Apr 15;31(9):866-872
pubmed: 32286929
J Biol Chem. 2004 Jul 2;279(27):28531-8
pubmed: 15123709
Nature. 2014 Nov 13;515(7526):209-15
pubmed: 25363760
Science. 2022 Jun 17;376(6599):eabf9088
pubmed: 35709258
Oncogene. 2004 Mar 15;23(11):2016-27
pubmed: 15021889
Nucleic Acids Res. 2007;35(6):e45
pubmed: 17317681
Brain. 2021 Sep 4;144(8):2527-2540
pubmed: 34014281
Development. 2020 Jun 22;147(21):
pubmed: 32467234
Neuron. 2022 Jan 19;110(2):195-208
pubmed: 34847355
Dev Biol. 2018 Oct 15;442(2):276-287
pubmed: 30096282
Mol Psychiatry. 2014 Oct;19(10):1115-24
pubmed: 25178163
CSH Protoc. 2007 May 01;2007:pdb.prot4734
pubmed: 21357079
Front Cell Neurosci. 2018 Jun 14;12:165
pubmed: 29962938
Dev Cell. 2020 Jul 6;54(1):7-20
pubmed: 32634400
Front Pediatr. 2022 Mar 30;10:844845
pubmed: 35433545
J Cell Sci. 2018 Jan 29;131(3):
pubmed: 29180514
Nature. 1996 Aug 1;382(6590):420-5
pubmed: 8684481
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4468-77
pubmed: 25294932
Neuron. 2012 Apr 26;74(2):285-99
pubmed: 22542183
Cell. 2001 Jan 12;104(1):95-106
pubmed: 11163243
Neuron. 2018 Oct 24;100(2):406-423
pubmed: 30359605
J Pharmacol Exp Ther. 2008 Apr;325(1):146-53
pubmed: 18199809
Mol Psychiatry. 2017 Jun;22(6):820-835
pubmed: 27378147
Nature. 2012 Apr 04;485(7397):237-41
pubmed: 22495306
Elife. 2023 Feb 15;12:
pubmed: 36790165
Nat Cell Biol. 2022 Jul;24(7):1088-1098
pubmed: 35725768
Cell. 2020 Feb 6;180(3):568-584.e23
pubmed: 31981491
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723

Auteurs

Micaela Lasser (M)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Nawei Sun (N)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Yuxiao Xu (Y)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Sheng Wang (S)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Sam Drake (S)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Karen Law (K)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Silvano Gonzalez (S)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Belinda Wang (B)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Langley Porter Psychiatric Institute, University of California, San Francisco, San Francisco, CA 94143, USA.

Vanessa Drury (V)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Octavio Castillo (O)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Yefim Zaltsman (Y)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Jeanselle Dea (J)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Ethel Bader (E)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Kate E McCluskey (KE)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.

Matthew W State (MW)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Langley Porter Psychiatric Institute, University of California, San Francisco, San Francisco, CA 94143, USA.
Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94143, USA.

A Jeremy Willsey (AJ)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94143, USA.

Helen Rankin Willsey (HR)

Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Chan Zuckerberg Biohub - San Francisco, San Francisco, CA 94158, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH